hVIVO plc (formerly Open Orphan plc)
Company Profile
Company website
Sector
Health Care Providers (Health Care Services)
Description
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
---two-page-company-summary-(march-2024).png "hVIVO (AIM HVO) - Two page Company summary (March 2024)")
Investor Access
10
Sep
Event information
The management will announce its interim results for the six months ended 30 June 2024 on Tuesday 10 September 2024.
Investors can sign up to Investor Meet Company for free and add to meet hVIVO plc via the following link: https://www.investormeetcompany.com/hvivo-plc-1/register-investorVenue
Online
Time
Tuesday 10 September 2024 at 6pm BST
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
